Mandate

Vinge advises Offentliga Hus i Norden AB (publ) in connection with its listing on Nasdaq First North Premier Growth Market

Vinge has advised Offentliga Hus i Norden AB (publ) (“Offentliga Hus”) in connection with its listing on Nasdaq First North Premier Growth Market (“Nasdaq First North Premier”). The prospectus was published on 13 October 2020 and the first day of trading on Nasdaq First North Premier was 23 October 2020.

The price in the offering was SEK 13.40 per share, corresponding to a market value of Offentliga Hus of SEK 3,430 million after the completion of the offering. The offering comprised 111,940,300 shares, of which 55,970,150 shares were newly issued shares and 55,970,150 were existing shares offered by Nordact AB.

Offentliga Hus is a growth-oriented property company with a focus on community service properties, where the tenants are predominantly, directly or indirectly, made up of public sector. The Company is geographically focused on larger and medium-sized cities in Sweden. By offering suitable premises at market conditions, Offentliga Hus are an attractive partner for the state, regions and municipalities in need of long-term and efficient property solutions.

Vinge’s team primarily consisted of David Andersson, William Kåge, Stephanie Stiernstedt and Lorin Arabi (Capital Markets and Public M&A), Maria Schultzberg, Henrik Wastenson and Victor Ericsson (Corporate tax), Mikael Ståhl and Felix Möller (Banking and Finance).

Related

Vinge has advised Verisure in connection with its IPO on Nasdaq Stockholm

Vinge has advised Verisure plc (“Verisure”) in connection with its IPO on Nasdaq Stockholm. Following the publication of the prospectus on 29 September 2025, trading in Verisure’s shares commenced today, 8 October 2025.
October 08, 2025

Vinge has acted for Advania on the acquisition of smartvokat

smartvokat GmbH, a German-based consultancy specialising in digital transformation within the legal, risk, and compliance domains, will become part of Advania’s business unit Transformation & Automation.
October 08, 2025

Vinge has advised Egetis Therapeutics in connection with a directed share issue

Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm, in connection with a directed share issue whereby Egetis Therapeutics raised proceeds of approximately SEK 183 million before transaction costs.
October 06, 2025